ABCL - AbCellera Biologics Inc.


2.03
-0.160   -7.882%

Share volume: 5,098,071
Last Updated: 05-06-2025
Pharmaceutical Products/Pharmaceutical Preparations: -0.13%

PREVIOUS CLOSE
CHG
CHG%

$2.19
-0.16
-0.07%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2023 06-30-2023 09-30-2023 12-31-2023 03-31-2024 06-30-2024 09-30-2024 12-31-2024
Fiscal Quarter Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Report Date 05-07-2024 08-03-2023 11-02-2023 11-04-2024 05-07-2024 08-06-2024 11-04-2024 02-27-2025
Total revenue 12.192 M 10.056 M 6.599 M 9.178 M 9.954 M 7.323 M 6.507 M 5.049 M
Cost of revenue 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Gross profit 12.192 M 10.056 M 6.599 M 9.178 M 9.954 M 7.323 M 6.507 M 5.049 M
    -17.52% -34.38% 39.08% 8.46% -26.43% -11.14% -22.41%  
Operating expenses 67.781 M 51.994 M 52.286 M 64.596 M 56.639 M 61.119 M 60.116 M 62.096 M
Selling general and admin 15.134 M 15.521 M 14.369 M 15.975 M 17.352 M 20.192 M 19.147 M 16.020 M
Research and development 52.647 M 36.473 M 37.917 M 48.621 M 39.287 M 40.927 M 40.969 M 46.076 M
Total expenses 77.066 M 61.445 M 61.489 M 75.232 M 64.848 M 100.777 M 100.170 M 77.804 M
    -20.27% 0.07% 22.35% -13.80% 55.40% -0.60% -22.33%  
Operating income -64.874 M -51.389 M -54.890 M -66.054 M -54.894 M -93.454 M -93.663 M -72.755 M
Ebit -57.907 M -48.783 M -50.016 M -59.570 M -53.148 M -57.988 M -72.235 M -55.497 M
Pretax income -48.148 M -38.004 M -39.276 M -48.601 M -42.747 M -48.187 M -62.632 M -46.829 M
    -21.07% 3.35% 23.74% -12.05% 12.73% 29.98% -25.23%  
Income tax -8.038 M -7.476 M -10.666 M -1.451 M -2.137 M -11.257 M -11.525 M -12.619 M
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                   
Net income -40.110 M -30.528 M -28.610 M -47.150 M -40.610 M -36.930 M -51.107 M -34.210 M
    23.89% 6.28% -64.80% 13.87% 9.06% -38.39% 33.06%